Results 31 to 40 of about 3,841 (191)

Application of serum SELDI proteomic patterns in diagnosis of lung cancer [PDF]

, 2005
Background Currently, no satisfactory biomarkers are available to screen for lung cancer. Surface-Enhanced Laser Desorption/ionization Time-of- Flight Mass Spectrometry ProteinChip system (SELDI-TOF-MS) is one of the currently used ...
Chen, Guoan, He, Da-cheng, Xiao, Xue-yuan, Yang, Shuan-ying, Zhang, Li-juan, Zhang, Wang-gang, Zhang, Wei, Zhou, Bin   +7 more
core   +2 more sources

Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations

Chinese Journal of Lung Cancer, 2016
Background and objective Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the standard first-line treatment regimen for EGFR mutated non-small cell lung cancer (NSCLC) patients. However, the efficacy of EGFR-TKIs widely varies.
Qunhui WANG, Hua ZHENG, Fanbin HU, Hongmei ZHANG, Ying HU, Jie LI, Tongmei ZHANG, Zan LIU, Baohua LU, Aimin HU, Baolan LI   +10 more
doaj   +1 more source

miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy. [PDF]

, 2015
MicroRNAs (miRNAs), a class of small non-coding RNAs, mediate gene expression by either cleaving target mRNAs or inhibiting their translation. They have key roles in the tumorigenesis of several cancers, including non-small cell lung cancer (NSCLC).
Cao, Yan, Huang, Pu-wen, Lou, Jian-fang, Pan, Shi-yang, Rao, Jian-yu, Shi, Xin-hui, Sun, Rui-hong, Wang, Fang, Wang, Hong, Wang, Peng, Xie, Er-fu, Xu, Jian, Xu, Ting   +12 more
core   +1 more source

Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer [PDF]

, 2008
Objective: To validate the prognostic value of preoperative levels of CYFRA 21-1, CEA and the corresponding tumor marker index (TMI) in patients with stage I non-small cell lung cancer (NSCLC). Methods: Two hundred forty stage I NSCLC patients (80 in pT1
Ankerst, Donna Pauler, Blankenburg, Florian, Gruber, Christine, Hatz, Rudolf, Nagel, Dorothea, Reinmiedl, Judith, Seidel, Dietrich, Stieber, Petra   +7 more
core   +1 more source

Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer

The International Journal of Biological Markers, 2019
From January 2018 to May 2018, 108 patients with thoracic esophageal cancer underwent esophagectomy with two- to three-field lymph node dissection.
Xinyu Mei, Xiaodong Zhu, Lei Zuo, Hanran Wu, Mingfa Guo, Changqing Liu   +5 more
doaj   +1 more source

Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured [PDF]

, 2015
Background Biomarkers can be subtle tools to aid the diagnosis, prognosis and monitoring of therapy and disease progression. The validation of biomarkers is a cumbersome process involving many steps. Serum samples from lung cancer patients were collected
Herth, Felix J., Kahn, Nicolas, Koch, Ina, Lindner, Michael, Meister, Michael, Muley, Thomas R., Rabe, Christina, Riedlinger, Julia, Roeßler, Markus, Schneider, Marc A., Schott-Hildebrand, Sabine   +10 more
core   +1 more source

Changes in three tumor markers in patients with advanced lung adenocarcinoma after combination therapy with pemetrexed and platinum: Short-term treatment efficacy [PDF]

, 2021
Purpose: To study changes in three tumor markers before and after combination treatment with pemetrexed and platinum, and evaluate the short-term therapeutic effectiveness of the treatment in advanced lung adenocarcinoma (ALA) subjects.
Chen, Xianguo, Li, Xianshuai, Lou, Yang, Xu, Bo, Xu, Xiaoyi   +4 more
core   +2 more sources

A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study

Life, 2021
Radon is a major cause of lung cancer (LC) deaths among non-smokers worldwide. However, no serum biomarker for screening of LC risk in high residential radon (HRR) areas is available. Therefore, the aim of this study was to determine diagnostic values of
Narongchai Autsavapromporn, Pitchayaponne Klunklin, Imjai Chitapanarux, Churdsak Jaikang, Busyamas Chewaskulyong, Patumrat Sripan, Masahiro Hosoda, Shinji Tokonami   +7 more
doaj   +1 more source

The application of CYFRA21-1 in cervical lesions screening in high-risk human papillomavirus infected women [PDF]

, 2016
Objectives: To investigate the role of cytokeratin-19 fragment (CYFRA21-1) in cervical lesions screening in high-risk hu­man papillomavirus (HR-HPV) infected women. Material and methods: The study was a retrospective study.
Jia, Yang, Yan-chun, Huang, Yang-chun, Feng   +2 more
core   +2 more sources

Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients [PDF]

, 2015
There is a clinical need for reliable biomarkers for lung cancer that permit early diagnosis of the disease and provide prediction of histological phenotype.
AG Serrano, AM Fiorenza, Andrew W. Fogarty, CH Oak, D Kong, David A. Barrett, David R. Baldwin, E Wojcik, GL May, H Ulmer, H Yang, Helen L. Barr, J Castro de, J Chee, J Dong, J Liu, JM Poczobutt, K Yanagisawa, K Yang, L Cheng, M Haag, M Hassanein, M Hassanein, M Murphy, MJ Wakelam, MR Wenk, P Brites, R Angelis de, RA Murphy, RA Murphy, RE Smith, RL Keith, RT Sreseli, S Cedres, Srinivasarao Ravipati, WJ Scott, X Gao, X Zeng, Y Guo, YY Tyurina, ZA Fernandis   +40 more
core   +1 more source